US Patent Issued to Sparrow Pharmaceuticals on June 17 for "Methods and compositions for treating glucocorticoid excess" (Oregon Inventor)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,745, issued on June 17, was assigned to Sparrow Pharmaceuticals Inc. (Portland, Ore.).

"Methods and compositions for treating glucocorticoid excess" was invented by David A. Katz (Portland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a method of treatment for glucocorticoid excess in a patient in need thereof, comprising administering to the patient a pseudo-irreversible HSD-1 inhibitor."

The patent was filed on April 8, 2024, under Application No. 18/629,056.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...